SX7EEX 📈 iShares EURO STOXX Banks - Overview
Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: DE0006289309 • Sector Equity Financial Services
SX7EEX: Banks, Financial, Services, Stocks, Bonds
The iShares EURO STOXX Banks 30-15 UCITS ETF (DE) EUR, traded under the symbol SX7EEX, is a financial instrument designed to track the performance of a specific segment of the European banking sector. It's a type of exchange-traded fund (ETF) that is domiciled in Germany, indicating that it is legally based and regulated within the German financial framework. The fund's company website can be found at http://www.iShares.de, providing investors with access to detailed information, performance data, and other relevant resources.
This ETF is categorized under Sector Equity Financial Services, meaning it focuses on investing in stocks of companies that operate within the financial services sector, specifically banks. The underlying index it tracks is the Morningstar Global Financial Services Index, which is a benchmark designed to measure the performance of companies in the financial services sector globally. The specific index this ETF follows is the Morningstar Gbl Fin Svc TME NR USD, with the ISIN DE0006289309, which helps in identifying the fund for trading and regulatory purposes.
As an ETF, it offers investors the ability to buy and sell the fund's shares on an exchange, similar to stocks, providing liquidity and flexibility. The UCITS (Undertakings for the Collective Investment in Transferable Securities) designation indicates that this fund complies with the European Union's regulatory framework for investment products, allowing it to be marketed and sold across EU member states. This compliance ensures a certain level of investor protection and standardization in how the fund operates and reports its activities.
The EURO STOXX Banks 30-15 UCITS ETF (DE) EUR is designed for investors looking to gain exposure to the European banking sector. By tracking a specific index, the fund aims to replicate the performance of that index, minus fees and expenses. Investors should consider their own financial goals, risk tolerance, and time horizon before investing in this or any other financial product. It's also important for potential investors to understand the fees associated with the fund, as well as any tax implications of investing in an ETF domiciled in Germany.
Additional Sources for SX7EEX ETF
SX7EEX ETF Overview
Market Cap in USD | 6,604,686m |
Category | Sector Equity Financial Services |
IPO / Inception | 2001-04-25 |
SX7EEX ETF Ratings
Growth 5y | 53.9% |
Fundamental | - |
Dividend | - |
Rel. Strength Industry | -17.9 |
Analysts | - |
Fair Price Momentum | 13.93 EUR |
Fair Price DCF | - |
SX7EEX Dividends
No Dividends PaidSX7EEX Growth Ratios
Growth Correlation 3m | 24.5% |
Growth Correlation 12m | 57.1% |
Growth Correlation 5y | 87.8% |
CAGR 5y | 9.13% |
CAGR/Mean DD 5y | 0.61 |
Sharpe Ratio 12m | 0.89 |
Alpha | 3.05 |
Beta | 0.69 |
Volatility | 19.76% |
Current Volume | 0k |
Average Volume 20d | 16.2k |
As of December 21, 2024, the stock is trading at EUR 14.08 with a total of 1 shares traded.
Over the past week, the price has changed by -1.16%, over one month by +2.05%, over three months by +1.33% and over the past year by +23.56%.
Partly, yes. Based on ValueRay Analyses, iShares EURO STOXX Banks (SW:SX7EEX) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.92 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SX7EEX as of December 2024 is 13.93. This means that SX7EEX is currently overvalued and has a potential downside of -1.07%.
iShares EURO STOXX Banks has no consensus analysts rating.
According to ValueRays Forecast Model, SX7EEX iShares EURO STOXX Banks will be worth about 15.3 in December 2025. The stock is currently trading at 14.08. This means that the stock has a potential upside of +8.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 15.3 | 8.9% |